ATP
Authorized Trading Partners
Under the Drug Supply Chain Security Act (DSCSA), trading partners must be able to demonstrate that they are authorized to engage in pharmaceutical distribution activities. This includes validating licensure status and maintaining confidence that transactions occur only between eligible organizations.
Incorporating ATP Context Into Supply
Chain Exchange
Maintaining confidence in trading partner eligibility is a foundational requirement under DSCSA. Organizations must ensure that the entities they transact with hold valid, active licenses appropriate to their role in the pharmaceutical supply chain and the jurisdictions in which they operate.
Licensing and authorization data is typically maintained by specialized providers that aggregate regulatory records, monitor status changes, and validate eligibility over time. These providers serve as the source of truth for determining whether a trading partner is permitted to engage in regulated activities.
Rather than duplicating these capabilities, Trust.med integrates with authorized trading partner data providers to incorporate licensing context into broader supply chain workflows. This allows organizations to reference up-to-date authorization status alongside EPCIS exchange, verification activity, and exception handling—helping ensure that data is shared only between eligible parties.
ATP Benefits
Eligibility Awareness
Understanding whether a trading partner is permitted to transact is foundational to compliant data exchange. By incorporating authorization status from trusted providers, organizations can ensure that interactions occur only between eligible parties.
Reduced Compliance Friction
Rather than treating partner authorization as a separate, manual check, ATP context can be referenced as part of routine supply chain workflows. This reduces operational friction while supporting alignment with DSCSA expectations.
Lower Risk Exposure
Outdated or incomplete partner information can introduce significant compliance risk. Access to current authorization data helps organizations avoid unintended transactions with ineligible entities and supports defensible audit outcomes.
Partner Alignment
When authorization status is consistently referenced across organizations, trading partners operate with a shared understanding of eligibility. This alignment improves coordination and reduces disputes related to licensing or registration discrepancies.
Understanding Authorized Trading Partner Requirements
EPCIS supports the ability to represent how individual product instances relate to larger logistical structures, such as cases or pallets. Rather than treating every item in isolation, this approach allows multiple serialized products to be associated with a higher-level container or handling unit.
By recording these relationships, supply chain activity can be monitored at the container level while still preserving the ability to reference each underlying item when needed. This structure simplifies operational visibility during storage, transport, and distribution without sacrificing detail or traceability.
Maintaining accurate parent–child relationships is especially important in regulated supply chains, where organizations must demonstrate control over product movement and maintain reliable records to support compliance obligations, including those defined under DSCSA.
"Trust.med ensures secure, uninterrupted access to critical pharmaceutical product information, enabling seamless data exchange, recall notifications, and product verification. More than just a technological tool, Trust.med aids in meeting the stringent DSCSA compliance requirements, enhancing the global discoverability of pharmaceutical product and location data."
Disrupt Magazine
Take the next step
Get a clearer understanding of how DSCSA data exchange works for pharmacies and where Trust.med can support your compliance strategy.